New research published in the Medical Journal of Australia has investigated the burden of the chronic lung disease bronchiectasis among Aboriginal and Torres Strait Islander adults in the Northern Territory Top End for the first time. Bronchiectasis is a lung condition where the walls of the airways widen and become thickened from inflammation and infection, explains Flinders University Professor Subash Heraganahally, a clinician based at Royal Darwin Hospital.
Journal/conference: Medical Journal of Australia
Link to research (DOI): 10.5694/mja2.52204
Organisation/s: Flinders University
Funder: This study was supported by the Thoracic Society of Australia and New Zealand (TSANZ) Robert Pierce Grant-In-Aid for Indigenous Lung Health. The TSANZ did not have any role in the study design, data collection, analysis, or interpretation.
From: Medical Journal of Australia (MJA)
New research published in the Medical Journal of Australia has investigated the burden of the chronic lung disease bronchiectasis among Aboriginal and Torres Strait Islander adults in the Northern Territory Top End for the first time.
Bronchiectasis is a lung condition where the walls of the airways widen and become thickened from inflammation and infection.
Bronchiectasis is Australia’s third most common chronic respiratory disorder, and is most commonly found in Indigenous populations in remote northern communities, with a devastating impact on life expectancy
The researchers analysed demographic data between 2011 and 2020 for Indigenous people with bronchiectasis in the four Top End Health Service health districts — Darwin Urban, Darwin Rural, East Arnhem, and Katherine — as well as any individual communities with ten or more active bronchiectasis cases.
In that period, 459 people were diagnosed with bronchiectasis via chest computed tomography (CT) scan, with an estimated prevalence of 19.4 bronchiectasis cases per 1000 residents.
The prevalence of the condition increased with age, peaking at 45.7 per 1000 people at age 50–59 years.
By 30 April 2023, 195 people with bronchiectasis recorded in the study had died (42.5%), at a median age of 60.3 years.
The researchers say targeted efforts are needed, calling for further investigation into the social, demographic and clinical determinants that contribute to high prevalence of bronchiectasis among Indigenous Australians in order to develop effective interventions and improve respiratory health outcomes.
“Targeted efforts are needed to overcome intrinsic and extrinsic barriers that impair access to specialist health care, and may account for marked differences between Indigenous and non-Indigenous people in bronchiectasis prevalence,” writes Dr Subash Heraganahally and colleagues.
Professor Heraganahally is a respiratory and sleep medicine specialist with the College of Medicine and Public Health at Flinders University, Darwin.
“Moreover, improving cultural sensitivity, education and awareness, early detection and diagnosis, treatment adherence, multidisciplinary care, preventing infections, smoking cessation, pulmonary rehabilitation, research and data collection, telehealth and telemedicine, and community involvement are all critical,” Dr Heraganahally and colleagues wrote.
Bronchiectasis among Indigenous adults in the Top End of the Northern Territory, 2011–2020: a retrospective cohort study (2024) by Claire Gibbs, Timothy Howarth, Adriana Ticoalu, Winnie Chen, Payi L Ford, Asanga Abeyaratne, Lata Jayaram, Gabrielle McCallum, Subash S Heraganahally has been published in the Medical Journal of Australia.
First published: 15 January 2024 https://doi.org/10.5694/mja2.52204
This study was supported by the Thoracic Society of Australia and New Zealand (TSANZ) Robert Pierce Grant-In-Aid for Indigenous Lung Health.